Dr. Curigliano Discusses Immunotherapy in Breast Cancer – OncLive
OncLive |
Dr. Curigliano Discusses Immunotherapy in Breast Cancer
OncLive Giuseppe Curigliano, MD, PhD, head of the Division of Early Drug Development at European Institute of Oncology, in Milan, Italy, discusses the emergence of immunotherapy in breast cancer. The combination of checkpoint inhibitors and chemotherapy is … |
